Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
12 hedge funds and large institutions have $49.2M invested in Zealand Pharma A/S American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more capital invested
Capital invested by funds: $42.1M → $49.2M (+$7.13M)
9% more funds holding
Funds holding: 11 → 12 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$416K |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$247K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$104K |
| 4 |
Morgan Stanley
New York
|
+$96.2K |
| 5 |
JP Morgan Chase
New York
|
+$73.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$4.17M |
| 2 |
Millennium Management
New York
|
-$1.11M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$5.51K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.94K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$513 |
ZEAL Hedge Fund Activity: Q3 2018 in Review
12 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q3 2018, worth a combined $49.2M — up 17% from $42.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ZEAL positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was State of Wisconsin Investment Board, opening a new position worth an estimated $416K. The largest seller was AWM Investment Company, exiting entirely with an estimated $4.17M sold.
- 12 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q3 2018, up from 11 in Q2 2018.
- Funds reported $49.2M of Zealand Pharma A/S American Depositary Shares stock for Q3 2018, up 17% quarter-over-quarter.
- 2 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q3 2018 and 1 closed out, a net change of +1 holder.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q3 2018 was State of Wisconsin Investment Board, an estimated $416K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q3 2018 was AWM Investment Company, an estimated $4.17M sold.
Based on aggregated 13F filings for Q3 2018.